🌐 EnglishEN

AI Cure is a research tool showing open data. Not medical advice. Discuss with your doctor. Terms

← Trials
🧪

Improved Prescribing for Older Nursing Home Patients

RecruitingNAAges 65 Years - anyAllAmsterdam UMC, location VUmc
NCT06731361 on ClinicalTrials.gov ↗
💬

In plain words

What the trial is, and whether it could suit you

Research aim: To investigate the effect of training health care professionals in medication assessments on the medication use of nursing home residents with a limited life expectancy (\< 1.5-2 years). The core of the training is to tailor medication use to (palliative) treatment goals of nursing home residents. Design: A cluster randomized controlled trial on long term care wards in nursing homes, with the nursing home care organisations as unit of randomisation. The investigators intent to include 6 organisations and 450 nursing home patients. The research starts in september and lasts 1 year and 3 months. Eligible patients are nursing home patients of 65 years and older with a limited life expectancy (\< 1.5-2 year) of long term care wards. Intervention: The intervention includes a method in which healthcare professionals (medical practitioner, pharmacist and care worker) are tra

Sign in to get the eligibility rules as simple questions to take to your doctor.

Sign in
📋 Eligibility rules (as published)
Inclusion Criteria: Nursing home patients: * Age 65years and above * Living at long term care wards in nursing homes * Living at a long term care ward for at least 4 weeks before start of the study Exclusion Criteria: * Temporary nursing home patients (i.e. geriatric rehabilitation or end-of-life/hospice care) * Life expectancy \< 4 weeks * Life expectancy clearly \> 1.5 - 2 years (i.e. patients with Huntingtons disease)
💊

What it tests

  • Systematic multidisciplinary medication review + ACP (SMMR+)
📍

Where

7 sites
Zorggroep Apeldoorn, location Randerode, De Hofstede and De Windkanter
Apeldoorn, Netherlands
Zorggroep Noordwest-Veluwe, locaties Weideheem en de Arcade
Harderwijk, Netherlands
Cordaan, location Nieuw Vredenburgh
Amsterdam, Netherlands
Amaris, Location Alporti and Rubina
Hilversum, Netherlands
AxionContinu, location Isselwaerde and de Schutse
IJsselstein, Netherlands
Zorgspectrum, location de Plataan
Vianen, Netherlands
Dignis, location de Veldspaat
Groningen, Netherlands
🤝 Taking part is your choice, and you can leave at any time. Only the trial team can confirm you are eligible — always decide together with your own doctor.
🛡️

AI Cure shows public evidence (Open Targets, ClinicalTrials.gov, PubMed, openFDA, DepMap, AlphaFold) with its source, and AI summaries that cite it — not medical advice and not a cure. Treatment decisions belong with your doctor. Research ideas are shared only with approved researchers and labs, who can test them. In an emergency call your local emergency number (112 in India and Europe, 911 in the US). AI Cure Terms of Use · Privacy